preDiCT

Many drugs fail to reach the market because of side effects on the heart. The principal objective of this proposal is to create an advanced computational technology for in silico assessment of the efficacy and safety of specific drugs [ICT-2007.5.3(c) (3)], i.e. an open environment comprising validated computational models, tools and numerical methods that will enable simulations of drug actions on the electrophysiology of the human heart.

Such simulations will involve modelling of drug interactions at the molecular and cellular level, will extend current technology to enable prediction of the effects of those interactions on the dynamics of the whole heart, and will lead to an understanding of how genetic factors can be used to assess patient-specific risk profiles. This requires a multi-level systems approach, based on multi-scale, multi-physics methods, including computations on adaptive spatial grids and multi-grid time integration. Computations on realistic models at appropriate spatial and temporal scales are currently not feasible, so we will investigate new algorithms and their implementation on high-performance platforms, including a new generation of petaflop computers, to achieve 'faster than real-time' simulation.

These tools form part of the infrastructure required to simulate the physiology of major organ systems, thereby contributing to the goal of creating the Virtual Physiological Human (VPH) [ICT-2007.5.3]. The balanced team in this project, including founders of the Human Physiome Project, has decades of experience in the experimental study and modelling of the electrophysiology and mechanics of the heart, while pharmaceutical industry partners bring deep understanding of the mechanisms of drug actions. The results will demonstrate the value of the VPH initiative to fundamental scientific understanding of the heart, with major economic and clinical impacts through accelerated drug development, approval and use.

For further information, please visit:
http://www.vph-predict.eu

Project co-ordinator:
The Chancellor, Master and Scholars of the University of Oxford

Partners:

  • F. Hoffmann-La Roche AG
  • Szegedi Tudományegyetem
  • Fujitsu Laboratories of Europe Limited
  • Glaxo Smithkline Research and Development
  • Universidad Politécnica de Valencia
  • Centro di Ricerca, Sviluppo e Studi Superiori in Sardegna
  • Novartis Pharma AG
  • Aureus Pharma SA

Timetable: from 06/2008 – to 05/2011

Total cost: € 5.545.692

EC funding: € 4.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Virtual physiological human

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Leading Health Systems Sign On to Delive…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the expanding adoption of its Population Health Management solutions with health systems across the globe, including...

Pflegetiger Adds Digital Health Ventures…

Since summer 2016, Pflegetiger has been developing its innovative concept of neighborhood care, a concept designed to make in-home care attractive for care professionals again. The company's revolutionary approach -...

Can Virtual Reality be Used to Manage Pa…

Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center. Children undergo necessary yet painful and distressing medical procedures...

Free iPhone App could Guide MS Research…

For some diseases, a simple blood test is all that's needed to estimate severity or confirm a diagnosis. Not so for multiple sclerosis. No single lab test can tell doctors...

Using Social Media Big Data to Combat Pr…

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral...

B.Braun Accelerator Call for Innovative …

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European...

'NHS Cyber Security Batsignal' Peer-to-P…

The two chairs of the largest independent communities of NHS digital leaders will launch the 'NHS Cyber Security Batsignal', a new peer-to-peer cyber security warning alerting system, at the first...

Giving Rookie Dads the Online Info they …

Expectant and new parents often turn to the internet for parenting prep, but it turns out that dads often don't seem to find the information they say they need about...

Artificial Intelligence to Evaluate Brai…

Researchers at the University of Helsinki and the Helsinki University Hospital (HUH), Finland, have developed software based on machine learning, which can independently interpret EEG signals from a premature infant...

FDA Approves Pill with Sensor that Digit…

The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor...

Philips Partners with Dutch Health Insur…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is collaborating with Dutch health insurer ONVZ to provide an industry first, strategic cooperation...